ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 32

$428K Total Retail Price of All Prescriptions

Rank: 6 out of 32

329 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 4,692 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
PRAVASTATIN SODIUM 409 228 1 10
OXYCODONE HCL-ACETAMINOPHEN 311 66 S2 2 60
FUROSEMIDE 275 191 3 5
HYDROCODONE-ACETAMINOPHEN 274 130 S3 4 1
AMLODIPINE BESYLATE 246 138 5 2
METFORMIN HCL 203 137 6 9
CLONIDINE HCL 201 105 7 31
NEXIUM 198 84 8 23
METOPROLOL TARTRATE 196 104 9 7
HYDROCHLOROTHIAZIDE 194 81 10 11
RANITIDINE HCL 193 83 11 12
LEVOTHYROXINE SODIUM 186 135 12 4
PROMETHAZINE HCL 156 50 R 13 59
ALLOPURINOL 147 119 14 26
OMEPRAZOLE 144 50 15 8
PREDNISONE 137 65 16 52
GLIPIZIDE 136 75 17 40
VENTOLIN HFA 134 37 18 65
LISINOPRIL 116 66 19 3
SERTRALINE HCL 114 80 20 24
DOXYCYCLINE HYCLATE 112 49 21 87
CIPROFLOXACIN HCL 105 53 22 35
PROAIR HFA 103 53 23 77
DIOVAN HCT 102 35 24 61
VERAPAMIL HCL 100 48 25 139
THEOPHYLLINE ANHYDROUS 98 46 26 140
KLOR-CON M20 96 66 27 54
GLIPIZIDE ER 92 90 28 118
ATORVASTATIN CALCIUM 89 87 29 15
CARVEDILOL 89 51 29 28
POTASSIUM CHLORIDE 88 53 31 14
GABAPENTIN 87 21 32 16
DIOVAN 84 58 33 42
COLCRYS 83 49 34 73
LANTUS 81 38 35 29
OXYCODONE-ACETAMINOPHEN 76 0 S2 36 104
INSULIN SYRINGE 75 47 37 75
ATENOLOL 69 30 38 17
CEPHALEXIN 62 17 39 48
SPIRIVA 60 48 40 107
CARISOPRODOL 60 16 R 40 93
METOPROLOL SUCCINATE 57 51 42 18
DONEPEZIL HCL 56 49 43 30
FLUOXETINE HCL 56 35 43 111
ENDOCET 55 17 S2 45 180
ADVAIR DISKUS 54 12 46 124
SIMVASTATIN 52 21 47 6
TRAMADOL HCL-ACETAMINOPHEN 50 31 48 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.